Howard R. Soule

Executive Vice President Chief Science Officer at Prostate Cancer Foundation

Howard R. Soule

Howard R. Soule

Executive Vice President Chief Science Officer at Prostate Cancer Foundation

Overview
RelSci Relationships

874

Number of Boards

5

Contact Data
Trying to get in touch with Howard R. Soule? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Howard R. Soule likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Milken Family Foundation

Relationship likelihood: Strong

Board Member & Medical Director at Prostate Cancer Foundation

Relationship likelihood: Strong

Chairman, Global Treatment Sciences Network at Prostate Cancer Foundation

Relationship likelihood: Strong

Founding Partner at Vectis Strategies

Relationship likelihood: Strong

President & Chief Executive Officer at Prostate Cancer Foundation

Relationship likelihood: Strong

Chief Financial Officer, Treasurer & Secretary at Prostate Cancer Foundation

Relationship likelihood: Strong

Vice Chairman at Epilepsy Foundation of America

Relationship likelihood: Strong

Chief Executive Officer at Windmil Therapeutics, Inc.

Relationship likelihood: Strong

Treasurer & Director at Epilepsy Foundation of America

Relationship likelihood: Strong

Director at Epilepsy Foundation of America

Relationship likelihood: Strong

Paths to Howard R. Soule
Potential Connections via
Relationship Science
You
Howard R. Soule
Executive Vice President Chief Science Officer at Prostate Cancer Foundation
Education
Ph.D. in Virology & Epidemiology

Baylor College of Medicine is a health sciences university that creates knowledge and applies science and discoveries to further education, healthcare and community service locally and globally.

Career History
Executive Vice President Chief Science Officer
Current

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Senior Fellow
Current

A nonprofit, nonpartisan think tank, the Milken Institute believes in the power of capital markets to solve urgent social and economic challenges and improve lives. To build a foundation of rigorous, independent research, it has assembled a respected team of economists, industry experts and scholars to analyze the issues and choices facing policymakers. It convenes a network of influential decision-makers from the private and public sectors to help transform ideas into action. The Milken Institute partners with global leaders in finance, business, government, science and philanthropy -- people with the vision and resources to make a significant impact.

Advisor
Prior - 2008

ProQuest Management invests in healthcare companies located in the US. The sectors in which they invest include biotech and pharmaceutical companies. The firm provides financing for seed to late-stage capital requirements and the firm invests in both public & private companies.

Boards & Committees
Member, Science Advisory Board
Current

Exosome Diagnostics, Inc. develops and commercializes biofluid-based diagnostics to deliver personalized precision healthcare that improves lives. Its novel exosome-based technology platform can yield comprehensive and dynamic molecular insights to transform how cancer and other serious diseases are detected, diagnosed, treated and monitored. The company was founded by Wayne D. Comper, Harvey J. Barnett and James R. McCullough and is headquartered in Waltham, MA.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 +
2012

The Prostate Cancer Foundation (PCF), formerly known as CaP CURE, is the world’s largest philanthropic source of support for prostate cancer research. PCF was founded in 1993 in order to discover better treatments and a cure for prostate cancer. As of 2012, PCF has raised more than $500 million for research and funded more than 1,600 research projects at nearly 200 institutions in 17 countries. In the past 2 years, 5 new drugs that extend the lives of men with metastatic prostate cancer have been approved by the FDA. PCF initiated and supported academic treatment science that fast-forwarded every one of these approvals.

Events
Speaker
Los Angeles, CA, United States
2013 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Speaker
Los Angeles, CA, United States
2012 Milken Institute Global Conference

Through a unique international agenda and some of the smartest speakers on the planet, the Milken Institute Global Conference tackles the world’s most difficult challenges in an array of fields - from finance and philanthropy, to the environment and education, to government and health.

Speaker
Los Angeles, CA, United States
2011 Milken Institute Global Conference

The 2011 Milken Institute Global Conference brings together some of the most extraordinary people in the world - from entrepreneurs and executives to philanthropists, scientists and Nobel laureates. Together they explore solutions to today's most pressing social, political and economic challenges.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Howard R. Soule. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Howard R. Soule's profile does not indicate a business or promotional relationship of any kind between RelSci and Howard R. Soule.